Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Thrombosis-Associated Risk Factors in Pediatrics and Adults Treated with Asparaginase-Containing Chemotherapy for ALL: A Systematic Review and Meta-Analysis.

Current oncology (Toronto, Ont.)·2026
Same author

First Report of Staged Adaptive Frameless Stereotactic Radiosurgery in 3 "Pulses" to Salvage Brain Metastases that Failed Previous Radiosurgery.

Neurosurgery·2026
Same author

Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).

Lancet regional health. Americas·2026
Same author

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors: Erratum.

The Journal of urology·2026
Same author

Frailty and health resource utilization in 5450 adults with acute myeloid leukaemia: A population-based study from Ontario, Canada.

British journal of haematology·2026
Same author

Gadolinium-Based Contrast Agents in the Follow-up of Pituitary Adenomas Following Transsphenoidal Surgery: Are Clinical Outcomes Affected?

AJNR. American journal of neuroradiology·2026

相关实验视频

Updated: Jun 24, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K

确定中枢神经系统参与 AML 的风险因素和结果.

Jack T Seki1, Georgina S Daher-Reyes2, Eshetu G Atenafu3

  • 1Leslie Dan Faculty of Pharmacy, Department of Medical Oncology Hematology, University of Toronto, 144 College St., Toronto, Ontario M5S 3M2, Canada.

Clinical lymphoma, myeloma & leukemia
|July 31, 2025
PubMed
概括
此摘要是机器生成的。

在急性髓性白血病 (AML) 中,中枢神经系统 (CNS) 透是严重的. 高白细胞计数 (WBC ≥40),升高的LDH,NPM1突变或11q23异常可识别中枢神经系统+查的高风险患者.

关键词:
急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.中枢神经系统的透.分子形状的分子形状.没有NGS,没有NGS.风险因素和结果

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K

相关实验视频

Last Updated: Jun 24, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 分子生物学分子生物学

背景情况:

  • 中枢神经系统 (CNS) 透是急性髓性白血病 (AML) 的严重并发症.
  • 预测AML中中枢神经系统疾病的分子因素尚未确定.

研究的目的:

  • 确定与AML患者中中枢神经系统透相关的分子和临床特征.
  • 评估这些因素对患者治疗结果的影响.

主要方法:

  • 对259名接受腰椎穿刺 (LP) 和内 (IT) 化疗的AML患者的回顾性分析.
  • 下一代测序 (NGS) 用于突变分析.
  • 单变量和多变量分析以确定与中枢神经系统+疾病的关联.

主要成果:

  • 31名患者 (11.97%) 确诊了中枢神经系统+疾病.
  • 在中枢神经系统+患者中,NPM1和FLT3突变更常见.
  • 中枢神经系统+的独立预测因素包括高白细胞 (WBC) 计数 (≥30或≥40 × 109/L),高乳酸脱酶 (LDH) 与NPM1突变相结合,以及11q23异常.

结论:

  • 对于高风险AML患者 (根据WBC,LDH,NPM1或11q23状态定义) 建议进行例行查LP和预防性IT化疗.
  • 这种方法可能有助于预防中枢神经系统疾病和复发.
  • 需要进一步的前性试验来验证这些发现.